FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

FDA Sends Collection of Info on Animal Drug AERs to OMB

12/16/2014

Federal Register Notice: FDA’s proposed collection of information “Records and Reports Concerning Experiences With App...

Guidance on Safety of BE Study Protocols

12/05/2014

Federal Register Notice: FDA is making available a draft guidance for industry entitled How to Obtain a Letter from FDA Stating th...

FDA Withdraws 23 NDAs, 68 ANDAs

12/05/2014

Federal Register Notice: FDA is withdrawing approval of 23 NDAs and 68 ANDAs from multiple applicants. The holders of the applicat...

Guidance on Pregnancy/Lactation Labeling for Drugs/Biologics

12/04/2014

Federal Register Notice: FDA is making available a draft guidance for industry entitled Pregnancy, Lactation, and Reproductive Pot...

FDA Changes Pregnancy Labeling of Drug/Biologics

12/04/2014

Federal Register Final rule: FDA is amending its regulations on the content and format of the “Pregnancy,” “Labo...

Info on Supplement CGMPs Sent to OMB

12/02/2014

Federal Register Notice: FDA’s proposed collection of information “Current Good Manufacturing Practice in Manufacturin...

Guidance on Tracing Rx Drugs

12/02/2014

Federal Register Notice: FDA is making available a draft guidance for industry: DSCSA Standards for the Interoperable Exchange of ...

Guidance on Infusion Pumps

12/02/2014

Federal Register Notice: FDA is making available final guidance entitled, Infusion Pumps Total Product Life Cycle; Guidance for In...

Guidance on SUPAC Manufacturing Equipment

12/02/2014

Federal Register Notice: FDA is making available a guidance: SUPAC: Manufacturing Equipment Addendum. It replaces the draft guidan...

Guidance on Product Labeling on the Absence of Latex

12/02/2014

Federal Register Notice: FDA is making available a guidance entitled Recommendations for Labeling Medical Products to Inform Users...